Detroit Teacher Sick-Outs Continue — Check The Updated CLOSINGS LIST • FULL STORY  
ProNAi Presents Cancer Drug Results, Expands Management TeamProNAi Therapeutics Inc., a cancer drug development company, said last week that it had concluded its initial human clinical trial of PNT2258, a new type of nucleic acid drug.

More From CBS Detroit

Daily J
Valenti and Foster

Watch & Listen